WT Asset Management Ltd Makes New Investment in Astera Labs, Inc. $ALAB

Key Points

• WT Asset Management bought 92,400 shares of Astera Labs in Q4 valued at approximately $15.37 million, representing about 0.6% of the fund's portfolio (its 29th largest position) and leaving the firm with a 0.05% stake in ALAB.
• Astera Labs posted strong Q4 results—$0.58 EPS (beat) and $270.6M revenue (up 91.8% YoY, also a beat)—and the stock carries a consensus "Moderate Buy" rating with a consensus target near $199.74.
• Despite heavy institutional ownership (~60.5%) and bullish analyst coverage, there has been significant insider selling recently (over 1.06M shares worth ~$150.8M in the last 90 days), which could pressure near‑term sentiment.

WT Asset Management Ltd purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 92,400 shares of the company's stock, valued at approximately $15,372,000. Astera Labs makes up approximately 0.6% of WT Asset Management Ltd's portfolio, making the stock its 29th largest position. WT Asset Management Ltd owned 0.05% of Astera Labs as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of ALAB. Assetmark Inc. grew its holdings in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after acquiring an additional 101 shares in the last quarter. Hilltop National Bank grew its holdings in shares of Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC purchased a new position in shares of Astera Labs during the 4th quarter valued at $33,000. National Bank of Canada FI grew its holdings in shares of Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company's stock valued at $39,000 after acquiring an additional 124 shares in the last quarter. Finally, Wexford Capital LP purchased a new position in shares of Astera Labs during the 3rd quarter valued at $39,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Citigroup assumed coverage on shares of Astera Labs in a research note on Thursday, April 2nd. They issued a "buy" rating and a $200.00 price objective for the company. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $250.00 price objective on shares of Astera Labs in a research note on Tuesday. Loop Capital assumed coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a "buy" rating and a $250.00 price objective for the company. UBS Group assumed coverage on shares of Astera Labs in a research note on Tuesday. They issued a "neutral" rating and a $180.00 price objective for the company. Finally, Barclays set a $165.00 price objective on shares of Astera Labs in a research note on Thursday, January 15th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $199.74.

Astera Labs Price Performance

Astera Labs stock opened at $212.84 on Friday. The firm has a market cap of $36.45 billion, a price-to-earnings ratio of 174.46, a P/E/G ratio of 3.89 and a beta of 1.78. Astera Labs, Inc. has a fifty-two week low of $62.31 and a fifty-two week high of $262.90. The firm has a fifty day moving average price of $133.87 and a two-hundred day moving average price of $154.02.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business's revenue was up 91.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Insider Activity

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the business's stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel owned 118,084 shares of the company's stock, valued at $12,725,912.68. The trade was a 7.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares of the company's stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,064,888 shares of company stock worth $150,764,723. Insiders own 12.50% of the company's stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Wall Street and institutions backing the story — multiple buy/outperform ratings and a cluster of price targets (median ~$215) plus large Q4 2025 institutional purchases (e.g., BlackRock) support bullish positioning and provide demand for the stock. Astera Labs gains as investors refocus on AI interconnect demand and upcoming earnings catalyst
• Positive Sentiment: AI-infrastructure narrative and upcoming earnings act as a near-term catalyst — investors are repositioning ahead of early‑May Q1 results and continue to value Astera’s role in solving data‑center connectivity bottlenecks (Aries/Scorpio product relevance). Cramer Names 'The Stocks That Got Away'
• Positive Sentiment: Favorable industry coverage highlights the company’s strategic positioning in AI data centers, reinforcing growth expectations. This thematic coverage can drive momentum among growth and thematic funds. Astera Labs: The Tollbooth for AI's Traffic Jam
• Neutral Sentiment: UBS initiated coverage with a Neutral rating — this provides liquidity and analyst visibility but is not an explicit endorsement; UBS’s target (~$180) is below the median of recent targets, which may cap upside for some investors. Astera Labs NASDAQ: ALAB Research Coverage Started at UBS Group
• Neutral Sentiment: Coverage pieces highlighting insider ownership and growth metrics signal interest from investors who track insider alignment, but these lists are informational rather than direct catalysts. April 2026's High Insider Ownership Growth Leaders
• Negative Sentiment: Significant insider selling — CEO Jitendra Mohan and other senior insiders have sold large blocks in April under 10b5-1 plans (reports show tens of millions in proceeds). Heavy insider liquidation can pressure sentiment and raise short‑term selling risk despite the company’s growth story. This AI Stock Has Tripled Since Its IPO. Its CEO Just Cashed In. Insider Selling: Astera Labs NASDAQ: ALAB CEO Sells $56,064,793.02 in Stock

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.